Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
This is a phase 3 study to evaluate the safety and efficacy of OmegaD softgels for the
treatment of dry eye disease. A daily dose of 2 OmegaD softgels dosed orally BID will be
compared to 2 placebo softgels dosed orally BID for 84 days. Approximately 164 subjects will
be evaluated for their signs and symptoms of dry eye disease and for safety throughout the
study.